Regeneron (REGN) Announces Dupixent is Now Approved in European Union for Severe Chronic Rhinosinusitis with Nasal Polyposis
Go back to Regeneron (REGN) Announces Dupixent is Now Approved in European Union for Severe Chronic Rhinosinusitis with Nasal Polyposis| Regeneron (NASDAQ: REGN) | Delayed: 618.03 +5.53 (0.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $612.50 | 52 Week High | $592.36 | |||
| Open | $607.92 | 52 Week Low | $325.35 | |||
| Day High | $621.79 | P/E | 162.21 | |||
| Day Low | $607.92 | EPS | $3.81 | |||
| Volume | 1,279,853 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 41.60 -0.18 (0.43%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.78 | 52 Week High | $44.76 | |||
| Open | $42.27 | 52 Week Low | $36.81 | |||
| Day High | $42.47 | P/E | N/A | |||
| Day Low | $41.47 | EPS | $0.00 | |||
| Volume | 10,855,605 | |||||

